Financials
Financial year 2025
Worth noting
- The team shrank two years in a row.
Gross margin
€ 1.3 million
▲ 4% vs 2024
Profit
Growing€ 218,045
▲ 21% vs 2024
Debts
Low€ 329,075
▼ 26% vs 2024
Metaptys from Leuven, company number BE0554664311, closed financial year 2025 with a result of € 218,045 after tax. For that financial year Metaptys recorded a gross margin of € 1.3 million and equity of € 1.3 million. Compared with financial year 2024, the result moved from € 180,898 to € 218,045. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 22, 2026.
What happened at Metaptys?
What happened at Metaptys in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- ADP VENTURES BV stepped down as director. NBB
- KINCON BV stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 218,045 (▲ 21% vs 2024). Source: NBB ↗
- MARA CONSULTING BV stepped down as director. NBB
- ADP VENTURES BV became a director. NBB
- KINCON BV became a director. NBB
- MARA CONSULTING BV became a director. NBB
- New establishment in Leuven. KBO
In short
From € 6.6 million profit in 2021 to € 218,045 profit in 2025.
Paid € 273 in corporate taxes since 2021.
Best year ever: 2021, with € 6.6 million profit.
On average € 177,400 of value added per employee in 2025.
A new publication or filing at Metaptys? We notify you, reason included.
Follow MetaptysNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2025 annual accounts
Director · represented by Matthias DE WITTE
Also active at: DROIA Facility Services, Aura Invest, B.C. Oncology +1 more
since 2021 · until 2026
Director · represented by Alexander DEPAUW
Also active at: DROIA Facility Services, Aura Invest, B.C. Oncology +1 more
since 2026 · until 2031
Director · represented by Matthias VAN WOENSEL
since 2023 · until 2029
Establishments
Establishment units
Physical locations of this company
Gaston Geenslaan 3
3001 Leuven
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 11 companies are registered at this address.
QUOMAK
€ 4.6 million gross margin · 2025
Perseus Biomics
€ 320,026 gross margin · 2025
ReWind Therapeutics
€ -528,262 gross margin · 2025
AUGUSTINE THERAPEUTICS
€ -1.7 million gross margin · 2025
Montis Biosciences
€ -2.1 million gross margin · 2025
+6 more
Details
- Company number
- 0554.664.311
- VAT number
- BE 0554.664.311
- Registered office
- Gaston Geenslaan 3, 3001 Leuven
- Names & denominations
- Metaptys
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 4 June 2014
- Peppol
- Active · Active since 20 Aug 2025
- Contact
- 000000000000
- Activities · NACE
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige gespecialiseerde wetenschappelijke en technische activiteiten
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overige technische testen en toetsen
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied